about
Targeting the intragraft microenvironment and the development of chronic allograft rejectionRegulatory B cells: an exciting target for future therapeutics in transplantationAspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cellsInhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejectionInterleukin 17 in vascular inflammation.Mouse models of arteriosclerosis: from arterial injuries to vascular grafts.A20 Haploinsufficiency Aggravates Transplant Arteriosclerosis in Mouse Vascular Allografts: Implications for Clinical Transplantation.Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries.The universal NF-kappaB inhibitor a20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells.Host-derived smooth muscle cells accumulate in cardiac allografts: role of inflammation and monocyte chemoattractant protein 1.Progenitor cells from the explanted heart generate immunocompatible myocardium within the transplanted donor heart.Human allograft rejection in humanized mice: a historical perspectiveDiversity of the CD4 T Cell Alloresponse: The Short and the Long of ItThe critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosisIntracellular MHC class II controls regulatory tolerance to allogeneic transplants.IFN-gamma primes intact human coronary arteries and cultured coronary smooth muscle cells to double-stranded RNA- and self-RNA-induced inflammatory responses by upregulating TLR3 and melanoma differentiation-associated gene 5.Impaired selectin-dependent leukocyte recruitment induces T-cell exhaustion and prevents chronic allograft vasculopathy and rejection.Innate immunity alone is not sufficient for chronic rejection but predisposes healed allografts to T cell-mediated pathologyA20-mediated modulation of inflammatory and immune responses in aortic allografts and development of transplant arteriosclerosis.Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110δ prevents chronic rejection of heart allograftsImpact of MHC class II incompatibility on localization of mononuclear cell infiltrates to the bronchiolar compartment of orthotopic lung allografts.CC chemokine receptor-1 activates intimal smooth muscle-like cells in graft arterial disease.Pulmonary hypertension associated with lung transplantation obliterative bronchiolitis and vascular remodeling of the allograftTransient lymphopenia breaks costimulatory blockade-based peripheral tolerance and initiates cardiac allograft rejectionKruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages.Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies.Granzymes and perforin in solid organ transplant rejection.Inflammation in cardiovascular tissue engineering: the challenge to a promise: a minireview.Stem cell origins of intimal cells in graft arterial disease.Apoptosis and transplantation tolerance.Tissue-intrinsic dysfunction of circadian clock confers transplant arteriosclerosis.Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cellsNeutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cellsIFN-gamma-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cellsCytomegalovirus and chronic allograft rejection in liver transplantationMouse model of alloimmune-induced vascular rejection and transplant arteriosclerosis.The consequence of biologic graft processing on blood interface biocompatibility and mechanics.Thematic review series: The immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease.Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigenInterleukin-1α Activity in Necrotic Endothelial Cells Is Controlled by Caspase-1 Cleavage of Interleukin-1 Receptor-2: IMPLICATIONS FOR ALLOGRAFT REJECTION.
P2860
Q26852762-0B3A66F4-08C7-47EF-9C81-8AC5C996CC98Q27015093-BCE4183D-2CC3-47DE-A005-4BA89ADA0AD2Q28199779-3E62B07D-20FC-493B-88BB-065A098676FDQ28752308-9015D0A7-6E96-47E9-80C3-B49105A92222Q30429445-AE61536E-E9EC-4FF5-949D-25AB591DACC5Q30481132-4C2B3A5A-2D68-4CE5-8F98-CA115BC9D035Q30826185-DA4CA31C-A243-480F-97E0-C99847AC5045Q33214938-9F7E0481-332E-4D60-8C09-DD1B6A142896Q33266888-7275F2AA-4238-44A5-9C08-1272D2B21CA7Q33399716-BE16B62A-1517-4AB8-A3BA-EE36D84518DCQ33568886-94C13B9F-66E9-4D99-80B9-81F52D8D0F11Q33577374-C58D264E-51C4-44DA-BFCE-73FCBBA94B06Q33603191-8822FBB1-F760-4A32-8B78-ACD33D25777EQ33770904-468BEA9C-77B7-42F3-B282-46BE0872638CQ33896888-76519260-0CC1-4B15-9088-22267E2A54CAQ33988307-7C5AD35C-EA31-46C1-AEA2-96CEBE4F0698Q34083011-FA767722-42A8-4160-B8F2-0BCACC6717F2Q34121197-46A7E2F9-1E3A-4817-BD76-9E06F31CC5FBQ34127817-050054D5-11C3-4D4A-9F0A-B51BB296DBBAQ34221228-C1B4547C-080E-4CDB-A4C6-08065E5A3342Q34313111-302C47C0-AB45-4AFC-9B25-06108A2437E5Q34378583-F3C095BC-6C41-4934-A4C0-CD9C58D6D657Q34392802-85249742-DC5E-433E-B9C6-249BF7E52AB5Q34438306-0F2ABE84-D0EF-4F1B-A5C2-DD6F929D8681Q34451870-DD1CA5E5-DAFE-465B-B53C-11A35FAEF08EQ34546358-7C452CAB-20FC-47C6-AED5-B3E63973FA6EQ35010452-15F83E95-DA15-4F72-8F61-812B95A60C6DQ35094708-4A467FD0-0AC6-49DC-89B0-3E55C3C81FE3Q35095437-D3E1A452-7138-4392-A15D-275BDE54F50DQ35129735-5A861F43-78C6-49A2-961F-98A5BC928E62Q35345992-F9DAB5AA-35BF-4ADF-9579-8B314083E387Q35465343-A7EB677E-0BD4-46B3-8ED1-EE4CD6EF02F2Q35613184-7D97D97F-327D-4AB5-AD82-8A24E37B0DC4Q35638639-210E927A-AB34-4A9A-8D60-D13C993CF363Q35819911-0CB89AC7-4323-4342-8DDE-E86627965622Q35975238-929B1D32-DEA1-49CB-8FF3-3C7BD5AFBD23Q35994925-F18AF7A9-8009-4D1F-9257-FA8DF6CB9750Q36099980-D5AB41E8-FD1B-4B09-8BDD-490181ECC5C2Q36111571-F611A026-307C-4872-A4AC-64AA4653FEA2Q36139955-A158C205-21BE-4312-9634-6319B8CB708A
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Chronic rejection.
@ast
Chronic rejection.
@en
Chronic rejection.
@nl
type
label
Chronic rejection.
@ast
Chronic rejection.
@en
Chronic rejection.
@nl
prefLabel
Chronic rejection.
@ast
Chronic rejection.
@en
Chronic rejection.
@nl
P1433
P1476
Chronic rejection.
@en
P2093
P304
P356
10.1016/S1074-7613(01)00119-4
P407
P577
2001-04-01T00:00:00Z